RecruitingNot ApplicableNCT07281118

Intercostal Cryoanalgesia in Double Lung Transplant Recipients


Sponsor

University of California, Los Angeles

Enrollment

148 participants

Start Date

Dec 16, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study is testing a new way to help manage pain after a double lung transplant. Instead of relying only on strong pain medicines like opioids, doctors will use a cold-therapy probe during surgery to help numb the nerves near the incision. Researchers want to see if this method can reduce the need for opioids and improve recovery.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Atricure CryoSPHERE MAX Probe for people with post-operative pain management. The study is currently recruiting participants at 3 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEAtricure CryoSPHERE MAX Probe

Patients will be treated intra-operatively with Atricure CryoSPHERE MAX Probe to 2 intercostal spaces above and below the thoracotomy incision for 1 minutes for each application during their double lung transplant procedure.


Locations(3)

University of California Los Angeles

Los Angeles, California, United States

University of California San Francisco

San Francisco, California, United States

Baylor University

Waco, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07281118


Related Trials